Skip to main content

Table 1 Univariate analyses for the determinants of plaque progression

From: High HbA1c levels correlate with reduced plaque regression during statin treatment in patients with stable coronary artery disease: Results of the coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects (COSMOS)

Factor β 95% CI p Value
BMI 0.766 0.017, 1.514 0.045
Use of ACE inhibitors −6.655 −12.604, –0.706 0.0286
Use of sulfonylureas 6.672 0.100, 13.244 0.0467
HbA1c 2.941 0.452, 5.429 0.0209
Evaluated plaque length −0.997 −1.698, –0.296 0.0057
Plaque volume −0.112 −0.174, –0.049 0.0006
Vessel volume −0.047 −0.080, –0.013 0.0067
Plaque area −0.918 −1.598, –0.238 0.0086
  1. BMI, body mass index.
  2. Parameters with p values <0.05 by univariate analysis are listed.